[vc_row][vc_column][vc_column_text]Manchester-based property company MCR Homes, part of the MCR Property Group, has submitted plans for a 99-apartment development on Bridgewater Canal in Altrincham.
The scheme on Wharf Road, the mixed-height building will vary between three to seven storeys and sit adjacent to the canal, which has undergone a significant transformation in recent years.
An existing brick warehouse on the site bordering the Bridgewater Canal will be demolished to make way for the scheme, which will provide a mix of one, two, and three-bed apartments, alongside six two-bed townhouses.
The development will offer views over the canal and is in walking distance to Altrincham town centre. It will include 104 car parking spaces – 100% provision for prospective residents – and 99 cycle spaces, as well as a 6,000sq ft internal courtyard for residents.
Designed by Leach Rhodes Walker as architect, the professional team also includes Savills as planner and Enzygo as transport planner and ecological consultant.
Chris Taylor, managing director at MCR Homes, said: “Following major investment in the town centre and its flagship market, Altrincham is more sought after than ever. The property market is booming – prospective buyers and renters are attracted to its excellent commutability to Manchester, boosted by the rail and Metrolink networks, fantastic local schools and amenities.”
Christian Gilham, director at Leach Rhodes Walker, said: “This dynamic residence will be a high quality gateway building for those coming to Altrincham via the canal. It is designed to enhance the landscape of the waterway while blending with the style and scale of the existing houses adjacent.”
Rob Haslam, director at Savills, said: “Wharf Road will add an attractive waterside building to the available homes in Altrincham and contribute to the long-term vision of regenerating the Bridgewater Canal, a major part of local industrial and natural heritage.”[/vc_column_text][/vc_column][/vc_row]
By creating an account you agree to our terms & conditions.